1st Quarter - Termination
THE CONSILIO GROUP for N BRERETON MEDICAL TECHNOLOGIES
Firm
Income
—
Expenses
—
Terminated
Jan 1, 2026
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
FenBlock is a patented, non-invasive medical device designed to help patients safely taper off prescribed fentanyl patches by gradually reducing the amount of medication absorbed through the skin.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRANDON KIRBY | Director of Government Relations |
| MARGARET LINEHAN | — |
| OLIVER MEISSNER | CEO |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.